Superparamagnetic iron oxide nanoparticles in clinical applications: current status and future perspectives

Zhanhang Guo1, Dongfang Liu2, Haiyan Zhang3

  • 1Jiangsu Key Laboratory for Cardiovascular Information and Health Engineering Medicine, Institute of Clinical Medicine, Nanjing Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210093, China.

Ebiomedicine
|December 4, 2025
PubMed
Summary

Iron oxide nanoparticles (IONPs) show promise in precision medicine for MRI, cancer, and iron deficiency. Advances address manufacturing and safety, paving the way for next-generation therapies.

Related Concept Videos